Continuing Education
Myeloma: From Current to Cutting Edge
Best Suited For: Pharmacist, Pharmacy Technician, Nurse
CE Credits: 1 hours
Activity Description
This educational activity reviews current and emerging treatment strategies across the multiple myeloma care continuum. Learners will explore the role of quadruplet therapy in the frontline setting for both transplant-eligible and transplant-ineligible patients, as well as the use of CAR T-cell therapies and BCMA-targeting bispecific antibodies in relapsed/refractory disease. The activity also focuses on applying available sequencing data to develop evidence-based treatment plans for patients with relapsed/refractory multiple myeloma.
CE Credit: 1 hour
Fee: This activity does not require payment to register.
Learning Objectives
- Discuss the role of quadruplet therapy in transplant-eligible and transplant-ineligible multiple myeloma and identify appropriate use in the frontline setting
- Review chimeric antigen receptor (CAR) T-cell therapies’ use in relapsed/refractory multiple myeloma
- Summarize the role of BCMA-targeting bispecific antibodies in the management of relapsed/refractory multiple myeloma
- Determine an evidence-based treatment plan for relapsed/refractory multiple myeloma with available sequencing data
Obtaining CE Credit
To receive credit, you must and complete all the steps found in the “Complete Credit Requirements” link provided by the registration confirmation email from LecturePanda You may also use this page to obtain CE credit. After following the link on this page to in order to receive credit:
- Reviewing the course learning materials.
- Confirming information provided on registration.
- Watching the CE video (if it is an enduring or on-demand CE activity) to its entirety
- Submitting the CE Code (disclosed towards the end of all CE activities)
- Completing all listed evaluations and CE assessments.
Credit requirements must be completed before the date of the activity. Upon completion, credit will be transmitted electronically to the ACPE. All transmitted will be viewable in your CPE Monitor profile within 24 hours.
